Cabaletta Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $74,660,000.

Profit Margin

Cabaletta Bio, Inc. (NASDAQ:CABA): Profit margin
2017 0 -250K
2018 0 -12.20M
2019 0 -15.09M
2020 0 -32.49M
2021 0 -45.53M
2022 0 -51.81M
2023 0 -67.67M

CABA Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
0000000
Cost of revenue
1.42M3.68M733K354K104K00
Gross profit
-1.42M-3.68M-733K-354K-104K00
Operating exp.
Research and development
55.42M39.3M32.49M21.37M11.67M4.46M0
Selling and marketing
000000-83.33K
Total operating expenses
74.66M54.13M46.31M33.83M18.68M6.19M250K
Operating income
-74.66M-54.13M-46.31M-33.83M-18.68M-6.19M-250K
Other income (expenses), net
6.98M1.16M24K494K1.74M-6.24M83.33K
Income before tax
-67.67M-52.97M-46.28M-33.33M-16.94M-12.20M-250K
Income tax expense
0-1.16M-757K-848K-1.84M-235K-333.33K
Net income
-67.67M-51.81M-45.53M-32.49M-15.09M-12.20M-250K
Earnings per share
Basic EPS
-1.65-1.77-1.77-1.4-0.63-0.84-0.01
Diluted EPS
-1.65-1.77-1.77-1.4-0.63-0.84-0.01
Data sourceData sourceData sourceData sourceData source